Cholecalciferol 15000 UNT/ML Oral Solution ( DrugBank: Cholecalciferol )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 75 | Cushing disease | 1 |
75. Cushing disease
Clinical trials : 203 / Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04844164 (ClinicalTrials.gov) | April 16, 2019 | 9/4/2021 | Vitamin D Metabolism in Patients With Endocrine Disorders | Prospective Non-randomised Controlled Study of Vitamin D Metabolism in Patients With Endocrine Disorders (Acromegaly, Cushing's Disease, Primary Hyperparathyroidism, Diabetes Mellitus Type 1) Treated With Cholecalciferol Bolus Dose | Pituitary ACTH Hypersecretion;Acromegaly;Diabetes Mellitus, Type 1;Primary Hyperparathyroidism | Drug: Cholecalciferol 15000 UNT/ML Oral Solution | Endocrinology Research Centre, Moscow | Russian Science Foundation | Recruiting | 18 Years | 60 Years | All | 240 | Phase 1 | Russian Federation |